Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
allergan
4
×
biotech
boston blog main
boston top stories
4
×
boulder/denver blog main
boulder/denver top stories
clinical trials
4
×
detroit blog main
detroit top stories
eli lilly
fda
indiana blog main
indiana top stories
life sciences
national
4
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
4
×
wisconsin top stories
amgen
glaxosmithkline
ipo
abbvie
black diamond therapeutics
bristol-myers squibb
cancer
genentech
medical device
What
bio
drugs
roundup
black
companies
diamond’s
fda
won
appetite
approval
arguments
august
big
biotech
bread
busy
butter
buyout
cancer
cash
class
commercialized
competitors
continue
days
debut
decades
decisions
devices
diabetes
diamond
drug
eli
giant
grabbed
hasn’t
hold
indication
leading
legacy
Language
unset
Current search:
allergan
×
national
×
" wisconsin blog main "
×
" boston top stories "
×
" clinical trials "
×
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More